»ï¼º¼¿ïº´¿ø(¿øÀå ÃÖÇÑ¿ë)ÀÌ Áö³ 8ÀÏ ÀÌ º´¿ø¿¡¼ ÀϺ» NPO Osaka Clinical Trials Network(ÓÞø¡îöÚ¦医ö½úÐ医Öû«Í«Ã«È,ÀÌ»çÀå Thoru Masaoka)¿Í Àӻ󿬱¸ °ü·Ã Çù¾àÀ» ü°áÇß´Ù.
ÃÖÇÑ¿ë ¿øÀå°ú Thoru Masaoka ÀÌ»çÀåÀº À̹ø Çù¾à½ÄÀ» ÅëÇØ ¡ãÀӻ󿬱¸°ü·Ã Çмú Á¤º¸ ¹× ±â¼ú Á¤º¸ ±³·ù ¡ã»óÈ£ ¼¼¹Ì³ª, ±³À° µî ¿¬±¸ È°¼ºÈ¸¦ À§ÇÑ ±³·ù È®´ë µîÀÇ ³»¿ëÀÌ ´ã±ä Çù¾à¼¸¦ ±³È¯Çß´Ù.
À̹ø Çù¾àÀ» °è±â·Î ÇÑÀÏ°£ Àӻ󿬱¸ºÐ¾ßÀÇ ¹ßÀüÀ» ÃËÁøÇÏ´Â °è±â°¡ µÉ °ÍÀ¸·Î º¸ÀδÙ.
ÇÑÆí À̹ø Çù¾à½Ä ÈÄ¿¡´Â ‘Research and Biotechnology Therapeutics and Regenerative Medicine Products in Japan’(ÀϺ»ÀÇ Ã·´Ü ÀÇ·á, ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ÀǾàÇ°ÀÇ ÀÓ»ó½ÃÇè È帧°ú °³¹ßÀÇ ½ÇÁ¦ ¿¹¿¡ °üÇÏ¿©)À̶ó´Â ÁÖÁ¦·Î ÀϺ» ±³Åä´ëÇÐ Koji Kawakami ±³¼öÀÇ Æ¯º°°¿¬ÀÌ ÁøÇàµÆ´Ù.